Simultaneous epicardial atrial fibrillation ablation and left atrial appendage ligation: early considerations

Vincenzo Tarzia,Matteo Ponzoni,Tea Lena,Gino Gerosa

DOI: https://doi.org/10.21037/acs-2023-afm-0178

2024-03-29

Annals of Cardiothoracic Surgery

Abstract:Simultaneous epicardial atrial fibrillation ablation and left atrial appendage ligation: early considerations

surgery,cardiac & cardiovascular systems

What problem does this paper attempt to address?

Clinical Implication of Real-Time Three-Dimensional Transesophageal Echocardiography in Percutaneous Transcatheter Left Atrial Appendage Closure with Amplatzer Cardiac Plug(ACP) Device for Non-Valvular Atrial Fibrillation Patients

Wang Bei,Yu Chan,Zhao Bowen,Jiang Chenyang,Fu Guosheng,Zhu Jun,Ye Yang,Yu Cong,Xiong Li

DOI: https://doi.org/10.3760/cma.j.issn.1004-4477.2017.03.002

2017-01-01

Abstract:Objective To evaluate the application value of real-time three-dimensional echocardiography (RT-3D TEE) in nonvalvular atrial fibrillation patients after transcatheter left atrial appendage closure (LAAC) with the Amplatzer Cardiac Plug (ACP).Methods The two-dimensional transesophageal echocardiography (2D TEE) and RT-3D TEE were performed in selected patients to measure the diameter of left atrial appendage ostium and landing zone,to observe left atrial appendage morphology and lobular distribution.These were also performed to guide the whole process of transcatheter LAAC with ACP,which included the atrial septal puncture,sheathing canal cruise,occluder device implantation,and verifying the stability of occluder device and releasing the device.It involved observing ACP occluder morphology,location,stability,surrounding residual shunt,whether influencing the mitral valve and left superior pulmonary vein flow,and pericardial effusion.Results A total of 15 patients (100％) successfully underwent LAAC with the ACP.The maximum diameter of left atrial appendage ostium by 2D-TEE measurement during operation was (20.5 ± 2.9)mm,located at 135°.The diameter of left atrial appendage landing zone was (17.1 ± 2.8) mm,located at 45°;(18.0 ± 4.0) mm,located at 90°;(22.1 ± 4.7)mm,located at 135°,respectively.The left atrial appendage morphology:2 had one leaf and 13 had two leaves or more,including 2 cases of bifoliate short neck shape.In 15 patients,6 cases of cauliflower type,2 cases of wind sock type,3 cases of chicken wing type,2 cases of cactus type and 2 cases of complex type.The proximal left atrial appendage morphology:3 cases of boot type,2 cases of wide mouth type,6 cases of narrow mouth type,2 cases of straight tube type,and 2 cases of bifoliate short neck type.There was no obvious residual shunt in all the patients at immediately post-operation.Conclusions In the transcatheter LAAC with the ACP,RT-3D TEE has important application value in the preoperative selection of patients,the choice of appropriate occluder,guidance of full-process monitoring during operation,the postoperative effect evaluation and so on.
Feasibility study on atrial fibrillation ablation with pulsed field ablation and concomitant occlusion of the left atrial appendage

Jennifer Beney,Roberto Galea,Georgios Siontis,Christoph Gräni,Thomas Kueffer,Nicolas Brugger,Tobias Reichlin,Lorenz Räber,Laurent Roten

DOI: https://doi.org/10.1093/europace/euae176

2024-07-02

Abstract:Aims: Atrial fibrillation (AF) ablation and left atrial appendage occlusion (LAAO) are increasingly performed as individual procedures. Pulsed field ablation (PFA) has significantly reduced procedure duration and may be advantageous for the combined approach. Methods and results: We have launched a programme for simultaneous AF ablation using PFA and LAAO for patients qualifying for both treatments and excluding those with a complex anatomy. We compare procedure duration and fluoroscopy time against individual procedures (either AF ablation or LAAO alone), all performed by the same operators and using consistent technologies. We performed the combined procedure in 10 patients (50% males; median age 70 years) and excluded 2 patients (17%) because of a complex left atrial appendage anatomy. No death, stroke, or major bleeding events, including pericardial effusion, occurred. For single-procedure comparison, 207 AF ablation procedures and 61 LAAO procedures were available. The total median procedure duration was 79 min (range 60-125) for the combined procedure, 71 min (25-241) for individual AF ablation (51 min without and 78 min with 3-dimensional electroanatomic mapping), and 47 min (15-162) for individual LAAO. The respective fluoroscopy times were 21 (15-26), 15 (5-44), and 10 (3-50) min. For the combined procedure, femoral vein access to last PFA application lasted 49 min (34-93) and LAAO added 20 min (15-37). Conclusion: Simultaneous PFA-based AF ablation and LAAO in carefully selected patients is feasible and safe and can be executed within a short overall procedure duration.
Left atrial appendage occlusion: basic and clinical

Nan Zhang,Wilber Su,Yuxin Li,Junxian Song,Tong Liu,Ruiqin Xie

DOI: https://doi.org/10.3389/fcvm.2023.1325397

IF: 3.6

2023-01-01

Frontiers in Cardiovascular Medicine

Abstract:EDITORIAL article Front. Cardiovasc. Med., 15 November 2023Sec. Cardiac Rhythmology Volume 10 - 2023 | https://doi.org/10.3389/fcvm.2023.1325397
Robotic-assisted left atrial appendage occlusion

Massimo Baudo,Amanda Yakobitis,Courtney Murray,Gianluca Torregrossa

DOI: https://doi.org/10.1510/mmcts.2024.065

2024-08-28

Abstract:Atrial fibrillation poses significant stroke risks, particularly in patients undergoing cardiac surgery. Left atrial appendage occlusion has emerged as a crucial strategy for stroke prevention, garnering a Class I recommendation. This paper presents a technical framework for performing robotic left atrial appendage occlusion as an isolated procedure or concurrently with robotic coronary artery bypass grafting using the AtriCure AtriClip Pro2 device.
Tissue oedema following pulsed field ablation recognized during a concomitant left atrial appendage closure procedure: a case report

Gemma Gaggiotti,Stefano Bordignon,Shota Tohoku,Boris Schmidt,Julian Kyoung-Ryul Chun

DOI: https://doi.org/10.1093/ehjcr/ytae495

2024-09-10

Abstract:Background: In patients with non-valvular atrial fibrillation (AF), at high stroke risk, and who are ineligible for long-term oral anticoagulation, the left atrial appendage closure (LAAC) could be an alternative to anticoagulation. Pulsed field ablation (PFA) is a new non-thermal method for cardiac ablation modality based on high-voltage electrical energy for irreversible electroporation. We first report a case of a concomitant PFA pulmonary vein isolation (PVI) and LAAC. Case summary: A 74-year-old female patient was referred to our department for PVI for persistent AF (CHA2DS2-VASc score 5). A concomitant percutaneous LAAC was proposed because of a history of previous cerebellar transient ischaemic attack despite continuous oral anticoagulation therapy. Pulmonary vein isolation was achieved with a pentaspline PFA catheter, and LAAC was performed with a WATCHMAN FLX™ device (Boston Scientific, Plymouth, MN, USA). After PVI, a swelling of the left atrial ridge was observed, yet a 27 mm LAAC device was successfully implanted. The follow-up transesophageal echo (TEE) after 6 weeks showed complete resolution of the oedema, no device-related thrombus, but a slight proximal tilting of the LAAC device without leakage could be observed. The 6-month follow-up demonstrated a stable sinus rhythm, no stroke, or bleeding events were recorded. Discussion: In this case of synchronous PFA-PVI procedure in AF and WATCHMAN FLX™ device implantation, the electroporation created an acute oedema at the ridge level which at the TEE follow-up after 6 weeks was resolved. This resulted in a slightly tilted WATCHMAN device position which was nevertheless stable and showed no leakage.
Pulsed‐field ablation of pulmonary vein and left atrial posterior wall combined with left atrial appendage occlusion as single procedure

Lorenzo Bianchini,Massimo Moltrasio,Gaetano Fassini,Selene Cellucci,Rita Sicuso,Valentina Ribatti,Maria Antonietta Dessanai,Francesca Pizzamiglio,Giulia Vettor,Benedetta Majocchi,Fabrizio Tundo,Stefania Riva,Corrado Carbucicchio,Claudio Tondo

DOI: https://doi.org/10.1111/pace.14823

2023-09-16

PACE - Pacing and Clinical Electrophysiology

Abstract:Pulmonary vein isolation and left atrial posterior wall ablation using the Farapulse system, followed by left atrial appendage occlusion, have been achieved as single combined procedure to treat long‐standing persistent atrial fibrillation in a patient at high hemorrhagic risk.
Left atrial appendage therapies: a new topic for the Heart Team

Stefano Branzoli,Fabrizio Guarracini,Massimiliano Marini

DOI: https://doi.org/10.21037/acs-2023-afm-10

2024-01-30

Annals of Cardiothoracic Surgery

Abstract:Left atrial appendage therapies: a new topic for the Heart Team

surgery,cardiac & cardiovascular systems
Combined left atrial appendage occlusion and catheter ablation procedure for left atrial arrhythmias: A real‐world, propensity‐matched analysis

Stefan Preisendörfer,Muhammad T. Ayub,Aakash Sheth,George Y. Jabbour,Madhurmeet Singh,Chinmay P. Patel,Hemal Gada,Aditya Bhonsale,Mehak Dhande,Nathan A. Estes,Krishna Kancharla,Dustin E. Kliner,Amber Makani,Aditi Naniwadekar,Alaa Shalaby,Virginia Singla,Andrew Voigt,Samir F. Saba,Sandeep K. Jain

DOI: https://doi.org/10.1111/jce.16466

IF: 2.7

2024-10-17

Journal of Cardiovascular Electrophysiology

Abstract:Introduction Real‐world studies comparing safety and efficacy of combined percutaneous left atrial appendage occlusion (LAAO) and catheter ablation (CA) to LAAO alone are limited. Methods Patients from a large US hospital system undergoing combined LAAO and left‐atrial CA from 8/2020 to 2/2024 were retrospectively analyzed and compared to a control group undergoing LAAO alone. Controls were identified using a 1:2 propensity score match based on LAAO device type (Watchman FLX vs. Amulet), CHA2D2‐VASc and Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio [INR], Elderly, Drugs/alcohol (HAS‐BLED) scores and compared for safety, sealing performance and clinical outcomes at 6 months. Results Patients were younger in the combined (n = 72) than in the control group (n = 144, 70.2 ± 7.3 vs. 76.7 ± 6.9 years, p

cardiac & cardiovascular systems
The left atrial appendage: An enigmatic friend or foe and implications of closure

John-Michael Benson,Jacob Keesee,Lincoln Smith,Jayden Navarro,Rami N Khouzam

DOI: https://doi.org/10.1016/j.cpcardiol.2024.102620

Abstract:The left atrial appendage (LAA) is often thought of as a vestigial organ serving as a nidus for clot formation in those with atrial fibrillation (A-fib). The LAA, however, has unique anatomy which allows it to serve special functions in the human body. Closing the LAA has been shown to decrease the risk of thromboembolic events in patients who cannot tolerate anticoagulation. Several methods of closure exist including percutaneous endocardial closure, epicardial closure, and surgical clipping. In addition to decreasing stroke risk, there appears to be physiologic changes that occur after LAA closure. This comprehensive review aims to describe the functions of the LAA, compare the different methods of closure, and propose a new method for identifying which patients may benefit from LAA closure versus anticoagulation based on each patients' individual comorbidities rather than their contraindications.
Vertigo and the processing of vestibular information: A review in the context of predictive coding

C. Klingner,H. Axer,S. Brodoehl,O. Witte

DOI: https://doi.org/10.1016/j.neubiorev.2016.09.009

2016-12-01

Abstract:
Concomitant atrial fibrillation ablation in minimally invasive cardiac surgery

Andrew Tjon Joek Tjien,Ferdi Akca,Kayan Lam,Jules Olsthoorn,Lukas Dekker,Pepijn van der Voort,Niels Verberkmoes,Thomas J van Brakel

DOI: https://doi.org/10.21037/acs-2023-afm-21

2024-01-30

Abstract:Concomitant atrial fibrillation (AF) ablation in cardiac surgery effectively restores sinus rhythm and may reduce morbidity and mortality. Cardiac surgery has witnessed the transition from the historical Cox Maze procedure to more modern and less invasive approaches for concomitant AF treatment. As minimally invasive cardiac surgery gains traction, ablation methods and careful patient selection become crucial to optimize results. Emerging techniques, including bipolar epicardial radiofrequency and endo/epicardial cryoablation, are central to these advances, targeting specific arrhythmogenic areas within the atria. While pulmonary vein isolation (PVI) is essential, it may be insufficient for patients with persistent or longstanding persistent AF. In such cases, left atrial posterior wall isolation has proven beneficial. Furthermore, recent studies emphasize the significance of left atrial appendage occlusion in concurrent AF treatments, highlighting its role in stroke risk reduction. Notably, the left atrium remains the focal point for concomitant AF surgery over the right, primarily due to concerns like high pacemaker implantation rates and complexities of right atrial ablation sets. Although guidelines support its widespread use, concomitant AF ablation outcomes vary based on patient selection, surgeon's expertise, and clinical context and thus the Heart Team's input is crucial for individualized decisions. In the upcoming sections, we present our patient selection and a visual guide to our techniques for concomitant AF surgery in minimally invasive mitral valve, coronary artery bypass and aortic valve surgery.
Application of combined ablation procedures via percutaneous epi/endocardial access in patients with recurrent atrial fibrillation

Lu Yu,Shiquan Chen,Ruhong Jiang,Zuwen Zhang,Qiang Liu,Pei Zhang,Chenyang Jiang

DOI: https://doi.org/10.3760/cma.j.issn.1007-6638.2017.03.005

2017-01-01

Abstract:Objective We aimed to evaluate the feasibility,safety and efficacy of combined ablation procedures via percutaneous epi/endocardial access in patients with recurrent atrial fibrillation (AF).Methods Twelve symptomatic patients with recurrent AF who received ablation at least twice before were enrolled in this study from September 2016 to January 2017.We did both epi/endocardial mapping and ablation via percutaneous subxiphoid pericardial and transseptal access guided by Carto 3 system (Biosence Webster,USA).The feasibility and perioperative complications were observed,and follow-up study was obtained.Results Totally 11 patients received both epicardial and endocardial mapping,and 10 of them underwent epicardial ablation.Endocardial mapping indicated that 7 patients still kept isolation of the 4 pulmonary veins (PVs),and further endo procedures terminated 4 atrial tachycardia(ATs) and blocked 6 ablation lines.Epicardial procedures terminated 3 ATs including one premature atrial contraction (PAC) and blocked 4 refractory ablation lines.No tamponade or other perioperative complications were observed during a mean follow-up of 3.8±1.4 months.Conclusion For refractory AF patients with repeated ablation,it might be safe and feasible to undergo mapping and ablation via both percutaneous epi/endocardial access.
Combined MitraClip and Left Atrial Appendage Occlusion: Is It Still a Utopia?

Martina Belli,Federico Zanin,Massimiliano Macrini,Lucy Barone,Massimo Marchei,Saverio Muscoli,Francesca Romana Prandi,Domenico Sergi,Marco Di Luozzo,Francesco Romeo,Francesco Barillà

DOI: https://doi.org/10.3389/fcvm.2022.940560

IF: 3.6

2022-07-12

Frontiers in Cardiovascular Medicine

Abstract:Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting 32 million individuals worldwide, particularly the elderly. It is the main cause of ischemic strokes. Oral anticoagulation (OAC) is the gold standard strategy for stroke prevention. Still, there is a not negligible share of patients who have contraindications to this therapy, more frequently due to an increased risk of bleeding. AF is often associated with moderate-severe mitral regurgitation (MR), the second most frequent valvular disease in elderly patients. Data from the literature reported that more than half of patients with severe mitral regurgitation are not suitable candidates for cardiac surgery. Given the progressive aging of the population and the simultaneous increase in the number of patients with comorbidities, the advent of new therapeutic strategies, such as the combined approach of Left Atrial Appendage Occlusion (LAAO) and MitraClip procedure, is acquiring great interest. At present, the category of patients who may benefit from combined percutaneous therapies and the long-term risks and benefits might not have been identified. Despite the efforts of researchers, the correct selection of patients is a very important clinical need that has not yet been met to avoid committing human and financial resources to interventions that may be unnecessary. It is conceivable that the most modern and recent innovations in cardiovascular imaging, particularly three-dimensional echocardiography and new methods of volume imaging, could improve our ability to select patients appropriately. Since data in the literature are scarce, future studies will be needed to evaluate the efficacy and safety of combined MitraClip and LAA occlusion.

cardiac & cardiovascular systems
First-in-Human Percutaneous Epicardial-Only Left Atrial Appendage Closure Using Sierra Left Atrial Appendage Ligation System

Jakub Batko,Radosław Litwinowicz,Boguslaw Kapelak,Krzysztof Bartuś

DOI: https://doi.org/10.3390/jcm13237417

IF: 3.9

2024-12-06

Journal of Clinical Medicine

Abstract:Background: In patients with atrial fibrillation and contraindications for oral anticoagulation, in which an increased risk of stroke remains, a left atrial appendage exclusion should be considered for elimination, because the left atrial appendage is the most common site of thrombus. The aim of this study is to present the first-in-human study results of the Sierra Aegis Left Atrial Appendage Ligation System, a new epicardial-only left atrial appendage closure system. Methods: This study was a prospective, first-in-human, single-center study evaluating the effectiveness and safety of the Sierra Aegis Left Atrial Appendage Ligation System device for epicardial left atrial appendage closure. Seven patients (mean age: 57.3 ± 10.6 years, 71.4% male) were qualified for a left atrial appendage closure because of an increased risk of bleeding with the need for lifelong anticoagulation pharmacology due to an increased risk of stroke. The patients' preoperative and intraoperative characteristics were collected. Patients were observed during their 1-month, 3-month, 6-month, and 1-year follow-up. Results: The mean procedure time was 21.2 ± 8.2 min. All patients spent 3 days in the hospital including monitoring, the performance of preoperative CT scans, and anatomical evaluation. No tamponade, bleeding, thrombus, or left atrial appendage leakage were observed during the procedure or in-hospital stay. During the 1-month, 3-month, 6-month, and 1-year follow-up visits, none of the patients reported any complications. No tamponade, leakage, or left atrial appendage thrombus were observed. Conclusions: This first-in-human study regarding Sierra use for left atrial appendage closure shows promising results regarding the effectiveness and safety of the Sierra device for use in humans.

medicine, general & internal
It's a long way to the top! Congenital venous anomalies and left isomerism limiting atrial fibrillation transcatheter ablation

Carlo De Innocentiis,Angela Buonpane,Antonio Totaro,Gennaro Restaino,Pasquale Astore,Martina Guarino,Valerio Langella,Sabina Gallina,Matteo Santamaria

DOI: https://doi.org/10.1016/j.cpcardiol.2024.102467

IF: 16.464

2024-05-01

Current Problems in Cardiology

Abstract:BACKGROUND: Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and it is associated with a high burden of mortality and morbidity worldwide. Catheter ablation is increasingly used to improve symptoms and prognosis in selected patients. Lower limb venous access with subsequent transseptal approach to the left atrium is the standard procedure for atrial fibrillation catheter ablation.CASE PRESENTATION: We report an unusual case of complex venous anomaly with a left-sided inferior vena cava with hemiazygos continuation to a persistent left superior vena cava draining in an enlarged coronary sinus in a patient with persistent atrial fibrillation scheduled for transcatheter ablation.DISCUSSION: Lower limb venous anomalies may limit a standard transseptal approach to the left atrium thus precluding an effective catheter ablation procedure for atrial fibrillation. Alternative interventions, such as unconventional percutaneous access, thoracoscopic approach and "ablate and pace" procedures, may be necessary in patients with symptomatic atrial fibrillation and complex venous anomalies.

cardiac & cardiovascular systems
Outcomes of hybrid surgical ablation and concomitant left atrial appendage exclusion in long‐standing persistent atrial fibrillation

Adnan Ahmed,Rachad Ghazal,Danish Bawa,Douglas Darden,Scott Koerber,Rishit Chilappa,Rajesh Kabra,Justin Van Meeteren,Ahmed Romeya,Rakesh Gopinathannair,Dhanunjaya Lakkireddy,Naga Venkata K. Pothineni

DOI: https://doi.org/10.1111/jce.16405

IF: 2.7

2024-08-23

Journal of Cardiovascular Electrophysiology

Abstract:Introduction Management of patients with long‐standing persistent atrial fibrillation (LSPAF) presents a clinical challenge. Hybrid convergent ablation has been shown to have superior efficacy compared to endocardial‐only ablation. However, data on concomitant left atrial appendage (LAA) management along with hybrid ablation is sparse. Methods We aimed to evaluate the effectiveness of concomitant hybrid convergent ablation and LAA clipping in patients with LSPAF. We conducted a retrospective analysis of all patients with LSPAF who underwent hybrid surgical ablation with LAA clipping at our institution. The primary endpoint was a recurrence of atrial arrhythmias at 12 months. Further, the durability of surgical left atrial posterior wall ablation was examined during the endocardial catheter ablation using standing electrophysiological criteria. Results A total of 79 patients were included. Mean age was 63.5 ± 9.6 years, and 71% were males. LAA clipping was performed in 99% of patients. The mean time between the surgical and endocardial stages of the procedure was 2.6 ± 1.7 months. Persistent posterior wall activity was observed in 34.2% (n = 27/79) patients during the endocardial phase of the procedure. Cardiac implantable electronic device was used in 74% of patients for monitoring of recurrence of atrial fibrillation (AF). The primary effectiveness of AF freedom at 12 months was 73.8% (45/61). Over a 12‐month follow‐up period, 11.4% (9/79) of patients required repeat catheter ablation, of which 88.9% (8/9) had evidence of persistent posterior wall activity. Conclusion Concomitant hybrid convergent ablation and LAA exclusion with an atrial clip provides reasonable long‐term AF‐free survival in patients with LSPAF. Persistent posterior wall activity is seen commonly in patients presenting with recurrent AF following hybrid convergent AF ablation.

cardiac & cardiovascular systems
Combining catheter ablation and left atrial appendage occlusion in high-risk patients with atrial fibrillation: a propensity score-matched analysis

Ziyong Hao,Bin Liu,Xiaoyi Xie,Yiting Fan,Jian Wang,Qin Shao,Lisheng Jiang,Ben He

DOI: https://doi.org/10.1016/j.hjc.2024.03.002

2024-03-07

Abstract:Background: The safety and efficacy of a combined approach of catheter ablation (CA) and left atrial appendage occlusion (LAAO) compared to LAAO alone remain unknown. Methods: Patients with atrial fibrillation (AF) at increased stroke risk who underwent LAAO were divided into either combined (CA and LAAO) procedures or LAAO alone group. Propensity score matching was utilized to balance baseline characteristics. The primary endpoint of the study was a composite of death, thromboembolic events, major bleeding, heart failure (HF) rehospitalization, and major periprocedural complications. Results: A total of 707 AF patients who underwent LAAO were included. After 1:1 propensity score matching, 166 patients who underwent LAAO alone (n = 83) or the combined procedure (n = 83) were analyzed. Successful LAAO was achieved in all (100%) patients, with a low incidence of periprocedural complications in both groups (2.4% vs. 4.8%, LAAO vs. combined, p = 0.68). The incidence of peri-device leak post-LAAO was significantly higher in the combined group (25.3% vs. 43.4%, p = 0.01). After a median follow-up of 2 years, there were no significant differences in the rates of the primary composite endpoint between the two strategies (22.2% vs. 14.3%, HR: 1.24 [95% CI: 0.51-2.97], p = 0.63). However, the rate of HF rehospitalization was significantly lower in the combined group (19.6% vs. 3.6%, HR: 4.89 [95% CI: 1.50-15.97], p = 0.024). Conclusions: Combining CA and LAAO in a "one-stop" approach is safe and brings additional benefits in relieving symptoms of heart failure, although peri-device leak was more common compared to LAAO alone.
Impact of pre-existing left atrial appendage occluder on catheter ablation of atrial fibrillation

Jien-Jiun Chen,Fu-Chun Chiu,Sheng-Nan Chang,Hsiao-Liang Cheng,Pang-shuo Huang,Cho-Kai Wu,Yi-Chih Wang,Juey-Jen Hwang,Chia-Ti Tsai

DOI: https://doi.org/10.1136/heartjnl-2022-321934

IF: 5.7

2023-02-07

Heart

Abstract:Background Patients with drug-refractory atrial fibrillation (AF) and pre-existing left atrial appendage occluder (LAAO) device may need pulmonary vein isolation (PVI). In this pioneer study, we investigated the impact of pre-existing LAAO on AF substrates and outcomes of PVI. Methods From our AF registry, 65 drug-refractory patients with LAAO (72.1±11.4 years old; CHA 2 DS 2 -VASc score 3.7±2.1) were included for PVI. A balanced control group with 124 patients without LAAO receiving PVI (70.9±10.2 years old, CHA 2 DS 2 -VASc 3.6±1.9) were included for comparison. Results We found PVI is feasible in patients with AF with pre-existing LAAO without new peridevice leak. Two patients with LAAO and one without LAAO had stroke during the procedure (2/65 vs 1/124, p=0.272). Complete isolation of left-sided PVs might not be achieved if the device covered the ridge joining the left atrial (LA) appendage to the body of LA. Local electrogram could be detected over LAAO and there was propagation of conduction over the occluder either under sinus rhythm or under atrial arrhythmia. LAAO might modulate LA substrate and induce peridevice fibrosis, peridevice LA flutter and complex fractionate atrial electrogram. The AF recurrent rate at 1 year was similar between the two groups (9.2% vs 8.8%). Conclusions This pioneer study first showed impacts of LAAO on LA substrate and PVI procedure.

cardiac & cardiovascular systems
Mammals of Eastern Equatorial Africa

H. Johnston

DOI: https://doi.org/10.1038/095510a0

IF: 64.8

1915-07-01

Nature

Abstract:
Focal atrial tachycardia originating from the left atrial appendage: electrocardiographic and electrophysiologic characterization and long-term outcomes of radiofrequency ablation.

Yun-Long Wang,Xue-Bin Li,Xin Quan,Jin-Xin Ma,Ping Zhang,Yuan Xu,Hai-Cheng Zhang,Ji-Hong Guo

DOI: https://doi.org/10.1111/j.1540-8167.2007.00808.x

IF: 2.7

2007-01-01

Journal of Cardiovascular Electrophysiology

Abstract:Introduction: This study sought to investigate electrophysiologic characteristics and radiofrequency ablation (RFA) in patients with focal atrial tachycardia (AT) arising from the left atrial appendage (LAA). Methods: This study included seven patients undergoing RFA with focal AT. Activation mapping was performed during tachycardia to identify an earlier activation in the left atria and the LAA. The atrial appendage angiography was performed to identify the origin in the LAA before and after RFA. Results: AT occurred spontaneously or was induced by isoproterenol infusion rather than programmed extrastimulation and burst atrial pacing in any patient. The tachycardia demonstrated a characteristic P-wave morphology and endocardial activation pattern. The P wave was highly positive in inferior leads in all patients. Lead V-1 showed upright or biphasic (+/-) component in all patients. Lead V-2-V-6 showed an isoelectric component in five patients or an upright component with low amplitude (< 0.1 mV) in two patients. Earliest endocardial activity occurred at the distal coronary sinus (CS) ahead of P wave in all seven patients. Mean tachycardia cycle length was 381 +/- 34 msec and the earliest endocardial activation at the successful RFA site occurred 42.3 +/- 9.6 msec before the onset of P wave. RFA was acutely successful in all seven patients. Long-term success was achieved in seven of the seven over a mean follow-up of 24 +/- 5 months. Conclusions: The LAA is an uncommon site of origin for focal AT (3%). There were consistent P-wave morphology and endocardial activation associated with this type of AT. The LAA focal ablation is safe and effective. Long-term success was achieved with focal ablation in all patients.

Simultaneous epicardial atrial fibrillation ablation and left atrial appendage ligation: early considerations

Clinical Implication of Real-Time Three-Dimensional Transesophageal Echocardiography in Percutaneous Transcatheter Left Atrial Appendage Closure with Amplatzer Cardiac Plug(ACP) Device for Non-Valvular Atrial Fibrillation Patients

Feasibility study on atrial fibrillation ablation with pulsed field ablation and concomitant occlusion of the left atrial appendage

Left atrial appendage occlusion: basic and clinical

Robotic-assisted left atrial appendage occlusion

Tissue oedema following pulsed field ablation recognized during a concomitant left atrial appendage closure procedure: a case report

Pulsed‐field ablation of pulmonary vein and left atrial posterior wall combined with left atrial appendage occlusion as single procedure

Left atrial appendage therapies: a new topic for the Heart Team

Combined left atrial appendage occlusion and catheter ablation procedure for left atrial arrhythmias: A real‐world, propensity‐matched analysis

The left atrial appendage: An enigmatic friend or foe and implications of closure

Vertigo and the processing of vestibular information: A review in the context of predictive coding

Concomitant atrial fibrillation ablation in minimally invasive cardiac surgery

Application of combined ablation procedures via percutaneous epi/endocardial access in patients with recurrent atrial fibrillation

Combined MitraClip and Left Atrial Appendage Occlusion: Is It Still a Utopia?

First-in-Human Percutaneous Epicardial-Only Left Atrial Appendage Closure Using Sierra Left Atrial Appendage Ligation System

It's a long way to the top! Congenital venous anomalies and left isomerism limiting atrial fibrillation transcatheter ablation

Outcomes of hybrid surgical ablation and concomitant left atrial appendage exclusion in long‐standing persistent atrial fibrillation

Combining catheter ablation and left atrial appendage occlusion in high-risk patients with atrial fibrillation: a propensity score-matched analysis

Impact of pre-existing left atrial appendage occluder on catheter ablation of atrial fibrillation

Mammals of Eastern Equatorial Africa

Focal atrial tachycardia originating from the left atrial appendage: electrocardiographic and electrophysiologic characterization and long-term outcomes of radiofrequency ablation.